New Livongo Family Care Plan available without a prescription or insurance

iPhone users will be able to share insulin dose data between apps, paving way for ecosystem with smart pens and connected pumps

Launch expected in 2018, possibly with no fingerstick calibration. Also, a 30% smaller transmitter and a new one-button inserter. Plus, what’s the latest on Medicare?

A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe

Get weekly email and phone notifications summarizing time-in-range and glucose trends from the updated Dexcom Clarity app

The most popular diabetes app in the world, mySugr offers coaching and tools to track blood sugar, medications, exercise, and “makes diabetes suck less”

Winning ideas aim to improve insulin safety, monitor for foot ulcers, and incorporate user insight into product development

Major win to complement Lilly’s partnership with Dr. Ed Damiano and the Bionic Pancreas team; insulin-only pivotal trial in late 2017/early 2018

Amalgam Rx receives FDA clearance for basal insulin dosing app, iSage Rx; available with a prescription to adjust Lantus, Levemir, Toujeo, Tresiba, and Basaglar

A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM

Third diabetes partnership for Fitbit, focused on integrating activity and sleep data with diabetes data on the phone and watch

Tidepool, the software nonprofit that collects data from diabetes devices, announces a major new project to drive better research and products from real-world data

First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company

Ease, comfort, and actionable patterns, but some challenges with insurance coverage

The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr

How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference

How one court ruling may reverse Medicare’s policy denying coverage of most CGMs

Device Updates from Abbott, Dexcom, Insulet, Medtronic, and Tandem

Results from the type 2 diabetes group in Dexcom’s DIaMonD trial show A1c and time-in-range benefits

Expected in 2017. Plus, the latest in the pipeline, including concentrated insulin systems and the Horizon Automated Glucose Control System